Home/Filings/4/0001209191-21-028843
4//SEC Filing

Queva Christophe 4

Accession 0001209191-21-028843

CIK 0001671818other

Filed

Apr 27, 8:00 PM ET

Accepted

Apr 28, 7:32 PM ET

Size

8.6 KB

Accession

0001209191-21-028843

Insider Transaction Report

Form 4
Period: 2021-04-26
Queva Christophe
CSO and SVP, Research
Transactions
  • Sale

    Common Stock

    2021-04-27$15.00/sh211$3,16577,165 total
  • Sale

    Common Stock

    2021-04-28$15.22/sh17,990$273,80859,175 total
  • Sale

    Common Stock

    2021-04-26$15.00/sh54$81077,376 total
Footnotes (3)
  • [F1]Shares were sold pursuant to a Rule 10b5-1 trading plan.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.04 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) and (3).
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.47 inclusive.

Issuer

Oncorus, Inc.

CIK 0001671818

Entity typeother

Related Parties

1
  • filerCIK 0001826523

Filing Metadata

Form type
4
Filed
Apr 27, 8:00 PM ET
Accepted
Apr 28, 7:32 PM ET
Size
8.6 KB